Recommendations for the management of tyrosinaemia type 1

被引：142
作者：
de Laet, Corinne [1 ]
Dionisi-Vici, Carlo [2 ]
Leonard, James V. [3 ]
McKiernan, Patrick [4 ]
Mitchell, Grant [5 ]
Monti, Lidia [6 ]
de Baulny, Helene Ogier [7 ]
Pintos-Morell, Guillem [8 ]
Spiekerkoetter, Ute [9 ]
机构：
[1] Univ Childrens Hosp Queen Fabiola, Dept Pediat, Nutr & Metab Unit, Brussels, Belgium
[2] Bambino Gesu Childrens Hosp IRCCS, Dept Pediat Med, Div Metab, Rome, Italy
[3] UCL Inst Child Hlth, London WC1N 1EH, England
[4] Birmingham Childrens Hosp, Liver Unit, Birmingham B4 6NH, W Midlands, England
[5] CHU St Justine, Dept Pediat, Montreal, PQ H3T 1C5, Canada
[6] Bambino Gesu Childrens Hosp IRCCS, Dept Radiol, Unit Hepatobiliary Imaging, Rome, Italy
[7] Hop Robert Debre, Reference Ctr Inherited Metab Dis, F-75019 Paris, France
[8] Badalona Univ Autonoma Barcelona, Univ Hosp Germans Trias & Pujol, Sect Paediat Nephrol Genet & Metab, Dept Paediat, Catalonia, Spain
[9] Univ Childrens Hosp, Dept Pediat & Adolescent Med, D-79106 Freiburg, Germany
来源：
ORPHANET JOURNAL OF RARE DISEASES | 2013年 / 8卷
关键词：
Hepatorenal tyrosinaemia; Fumarylacetoacetase; Succinylacetone; Nitisinone; Cirrhosis; Acute live failure; Hepatocellular carcinoma; Low tyrosine diet; LIVER LESION DETECTION; HEREDITARY TYROSINEMIA; NTBC TREATMENT; NITISINONE;
D O I：
10.1186/1750-1172-8-8
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
The management of tyrosinaemia type 1 (HT1, fumarylacetoacetase deficiency) has been revolutionised by the introduction of nitisinone but dietary treatment remains essential and the management is not easy. In this review detailed recommendations for the management are made based on expert opinion, published case reports and investigational studies as the evidence base is limited and there are no prospective controlled studies. The added value of this paper is that it summarises in detail current clinical knowledge about HT1 and makes recommendations for the management.
引用
收藏
页数：9
相关论文
共 43 条
  • [21] Tyrosinernia type I treated by NTBC: How does AFP predict liver cancer?
    Koelink, C. J. L.
    van Hasselt, P.
    van der Ploeg, A.
    van den Heuvel-Elbrink, M. M.
    Wijburg, F. A.
    Bijleveld, C. M. A.
    van Spronsen, F. J.
    [J]. MOLECULAR GENETICS AND METABOLISM, 2006, 89 (04) : 310 - 315
  • [22] LC-MS/MS Method for Simultaneous Determination on a Dried Blood Spot of Multiple Analytes Relevant for Treatment Monitoring in Patients with Tyrosinemia Type I
    la Marca, Giancarlo
    Malvagia, Sabrina
    Materazzi, Serena
    Della Bona, Maria Luisa
    Boenzi, Sara
    Martinelli, Diego
    Dionisi-Vici, Carlo
    [J]. ANALYTICAL CHEMISTRY, 2012, 84 (02) : 1184 - 1188
  • [23] Larochelle J, 2012, MOL GENET METAB
  • [24] Effect of nitisinone (NTBC) treatment on the clinical course of hepatorenal tyrosinemia in Quebec
    Larochelle, Jean
    Alvarez, Fernando
    Bussieres, Jean-Francois
    Chevalier, Isabelle
    Dallaire, Louis
    Dubois, Josee
    Faucher, Frederic
    Fenyves, Daphna
    Goodyer, Paul
    Grenier, Andre
    Holme, Elisabeth
    Laframboise, Rachel
    Lambert, Marie
    Lindstedt, Sven
    Maranda, Bruno
    Melancon, Serge
    Merouani, Aicha
    Mitchell, John
    Parizeault, Guy
    Pelletier, Luc
    Phan, Veronique
    Rinaldo, Piero
    Scott, C. Ronald
    Scriver, Charles
    Mitchell, Grant A.
    [J]. MOLECULAR GENETICS AND METABOLISM, 2012, 107 (1-2) : 49 - 54
  • [25] TREATMENT OF HEREDITARY TYROSINEMIA TYPE-I BY INHIBITION OF 4-HYDROXYPHENYLPYRUVATE DIOXYGENASE
    LINDSTEDT, S
    HOLME, E
    LOCK, EA
    HJALMARSON, O
    STRANDVIK, B
    [J]. LANCET, 1992, 340 (8823) : 813 - 817
  • [26] Tyrosinemia produced by 2-(2-nitro-4-trifluoromethylbenzoyl)-cyclohexane-1,3-dione (NTBC) in experimental animals and its relationship to corneal injury
    Lock, Edward A.
    Gaskin, Peter
    Ellis, Martin
    Provan, William M.
    Smith, Lewis L.
    [J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 2006, 215 (01) : 9 - 16
  • [27] Tyrosinemia type 1 in Spain: Mutational analysis, treatment and long-term outcome
    Luz Couce, Maria
    Dalmau, Jaime
    del Toro, Mireia
    Pintos-Morell, Guillem
    Aldamiz-Echevarria, Luis
    [J]. PEDIATRICS INTERNATIONAL, 2011, 53 (06) : 985 - 989
  • [28] NTBC treatment in tyrosinaemia type I: Long-term outcome in French patients
    Masurel-Paulet, A.
    Poggi-Bach, J.
    Rolland, M. -O.
    Bernard, O.
    Guffon, N.
    Dobbelaere, D.
    Sarles, J.
    de Baulny, H. Ogier
    Touati, G.
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2008, 31 (01) : 81 - 87
  • [29] Newborn screening for Tyr-I: Two years' experience of the New York State program
    Morrissey, M. A.
    Sunny, S.
    Fahim, A.
    Lubowski, C.
    Caggana, M.
    [J]. MOLECULAR GENETICS AND METABOLISM, 2011, 103 (02) : 191 - 192
  • [30] Focal liver lesion detection and characterization with diffusion-weighted MR imaging: Comparison with standard breath-hold T2-weighted imaging
    Parikh, Tejas
    Drew, Stephen J.
    Lee, Vivian S.
    Wong, Samson
    Hecht, Elizabeth M.
    Babb, James S.
    Taouli, Bachir
    [J]. RADIOLOGY, 2008, 246 (03) : 812 - 822
12345